Toxic

    Will Bayer survive its toxic takeover of Monsanto? Already Bayer’s stock value declined 44% since the $63bn buyout a year ago, and now a US court has granted $2bn in damages to a couple that claimed Roundup, the glyphosate-based weed killer, caused their cancer. This follows $2.5bn in damages from two cases last year – and there are 13,400 similar US lawsuits pending. Add the evidence of toxic lobbying revealed by the leaked Monsanto Papers and Bayer’s reputational damage starts to look as catastrophic as its mounting legal liabilities. Are we seeing the true cost of unsustainable business?

    — Wayne Visser

    More on Business & Finance

    From Purpose Inspired: Reflections on Conscious Living, Volume 1. Buy on Lulu ↗